Dr. Paul Friedman insists he wasn't distracted by the woman in the second row wearing a pair of wings and a rainbow bodysuit. And he didn't even seem to notice when a visitor teleported into the ...

DR. PAUL A. FRIEDMAN has been Chief Executive Officer of Incyte Corporation since November 2001. Prior to joining Incyte, Dr. Friedman was President of R&D for DuPont Pharmaceuticals Research ...

Currently, Dr. Friedman serves as Chairman and Chief Executive Officer of Madrigal Pharmaceuticals, Inc., following its merger with Synta Pharmaceuticals Corporation in July 2016.

HOUSTON, TX--(Marketwire - Oct 4, 2012) - Drs. Paul Friedman and Jennifer Peterson, physicians of Houston dermatology, have recently adopted an innovative technology to combat the appearance of ...

Dr. Friedman was the Chief Executive Officer of Incyte Corporation from November 2001 until his retirement in January 2014 and oversaw the development and commercialization of Jakafi®. Dr.

CoolSculpting isn’t intended to help people lose significant amounts of weight, though. “This is not a weight-loss treatment,” said Dr. Paul M. Friedman, a dermatologist in Houston and the ...

HOUSTON, TX--(Marketwire - Oct 4, 2012) - Drs. Paul Friedman and Jennifer Peterson, physicians of Houston dermatology, have recently adopted an innovative technology to combat the appearance of ...

Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced the appointment of Paul A. Friedman, M.D. to ...